Du F - Search Results

1

Is it safe to give anthracyclines concurrently with trastuzumab in neo-adjuvant or metastatic settings for HER2-positive breast cancer? A meta-analysis of randomized controlled trials.

Du F, Yuan P, Zhu W, Wang J, Ma F, Fan Y, Xu B. Du F, et al. Med Oncol. 2014 Dec;31(12):340. doi: 10.1007/s12032-014-0340-x. Epub 2014 Nov 22. Med Oncol. 2014. PMID: 25416049

2

The role of hypoxia-inducible factor-2 in digestive system cancers.

Zhao J, Du F, Shen G, Zheng F, Xu B. Zhao J, et al. Among authors: du f. Cell Death Dis. 2015 Jan 15;6(1):e1600. doi: 10.1038/cddis.2014.565. Cell Death Dis. 2015. PMID: 25590810 Free PMC article. Review.

3

Effect of hormone therapy on long-term outcomes of patients with human epidermal growth factor receptor 2- and hormone receptor-positive metastatic breast cancer: real world experience in China.

Du F, Yuan P, Wang JY, Ma F, Fan Y, Luo Y, Xu BH. Du F, et al. Asian Pac J Cancer Prev. 2015;16(3):903-7. doi: 10.7314/apjcp.2015.16.3.903. Asian Pac J Cancer Prev. 2015. PMID: 25735380 Free article.

4

Phase II multi-center clinical study on using S-1 to treat advanced breast cancer after resistance to anthracycline and taxane drugs in Chinese patients.

Yuan P, Di LJ, Liu W, Wan DG, Dai H, Tong ZS, Du F, Xu BH. Yuan P, et al. Among authors: du f. Int J Clin Exp Med. 2015 Feb 15;8(2):3072-9. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 25932284 Free PMC article.

5

The emerging role of hypoxia-inducible factor-2 involved in chemo/radioresistance in solid tumors.

Zhao J, Du F, Luo Y, Shen G, Zheng F, Xu B. Zhao J, et al. Among authors: du f. Cancer Treat Rev. 2015 Jul;41(7):623-33. doi: 10.1016/j.ctrv.2015.05.004. Epub 2015 May 9. Cancer Treat Rev. 2015. PMID: 25981453 Review.

6

S-1 and Cisplatin With or Without Nimotuzumab for Patients With Untreated Unresectable or Metastatic Gastric Cancer: A Randomized, Open-Label Phase 2 Trial.

Du F, Zheng Z, Shi S, Jiang Z, Qu T, Yuan X, Sun Y, Song Y, Yang L, Zhao J, Wang J, Chi Y. Du F, et al. Medicine (Baltimore). 2015 Jun;94(23):e958. doi: 10.1097/MD.0000000000000958. Medicine (Baltimore). 2015. PMID: 26061330 Free PMC article. Clinical Trial.

7

The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review.

Du F, Yuan P, Wang T, Zhao J, Zhao Z, Luo Y, Xu B. Du F, et al. Med Res Rev. 2015 Nov;35(6):1300-15. doi: 10.1002/med.21362. Epub 2015 Aug 27. Med Res Rev. 2015. PMID: 26313026 Review.

8

Cross-talk between EPAS-1/HIF-2α and PXR signaling pathway regulates multi-drug resistance of stomach cancer cell.

Zhao J, Bai Z, Feng F, Song E, Du F, Zhao J, Shen G, Ji F, Li G, Ma X, Hang X, Xu B. Zhao J, et al. Among authors: du f. Int J Biochem Cell Biol. 2016 Mar;72:73-88. doi: 10.1016/j.biocel.2016.01.006. Epub 2016 Jan 16. Int J Biochem Cell Biol. 2016. PMID: 26783937

9

[Efficacy and toxicity of vinorelbine (NVB)-based regimens in patients with metastatic triple negative breast cancer (mTNBC) pretreated with anthracyclines and taxanes].

Du F, Yuan P, Luo Y, Wang J, Ma F, Cai R, Fan Y, Li Q, Zhang P, Xu B. Du F, et al. Zhonghua Zhong Liu Za Zhi. 2015 Oct;37(10):788-92. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26813602 Chinese.

10

Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China.

Zhao J, Zhao J, Du F, Zhang Y, Shen G, Zhu H, Ji F, Ma F, Dong L, Kan J, Zheng F, Chen H, Wang Z, Xu B. Zhao J, et al. Among authors: du f. J Gastrointest Surg. 2016 Apr;20(4):700-7. doi: 10.1007/s11605-016-3089-z. Epub 2016 Feb 1. J Gastrointest Surg. 2016. PMID: 26831062

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,744 results

Search Page

Filters